Unlock the potential of FMD with BD Rowa Technologies


The Falsified Medicines Directive (FMD) will be rolled out in Europe from February 2019 to help address the threat of counterfeit medicines in the market and will impact the entire pharmacy supply chain. This rollout will see the introduction of two new safety features to every pack of medicine on the market – a 2D data matrix (bar code) ensuring the individual identity of each item, and an anti-tamper device.


With BD Rowa Technologies, the perceived uncertainty caused by the introduction of FMD could help unlock potential in your business.


Automatic loading of stock*, with 2D barcode scanning and data uploaded into your PMR system**


FMD ‘verification scan’


Visibility of exact expiry dates, and prioritised output by expiry date from your robot. Automated batch recalls


Completed Rx can be stored within your robot (StoreRx), avoiding the need for recommissioning


* Requires Rowa Prolog ** Requires PMR to be connected to the NMVD, and interfaced via BD Rowa’s new WWKS2 (Mosaic) interface.


For more information on FMD and how BD Rowa Technologies can help you unlock the potential in your business, go to www.bd.com/rowa


Rowa® Technologies © 2018 BD. All rights reserved. BD, the BD Logo, Rowa, and all other trademarks are property of Becton, Dickinson and Company. 0000MS08072 iss1 | 04/2018


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48